New tool for throat surgery aims to ease swallowing trouble
NCT ID NCT07496840
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how safe and effective a new device, the Speedboat UltraSlim™, is when used for a surgery called POEM in people with achalasia or other throat muscle problems. The surgery is already standard care, and researchers will track symptom improvement and any side effects for up to a year. About 40 adults will take part, and no extra treatments or tests are required beyond normal care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients diagnosed with achalasia or other esophageal motility disorders who are undergoing clinically indicated per-oral endoscopic myotomy (POEM) using the Speedboat UltraSlim™ device as part of standard clinical care. Patients are identified through routine clinical practice and enrolled prospectively after providing informed consent.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult patients (≥18 years of age) * Diagnosed with achalasia or other esophageal motility disorders * Scheduled to undergo clinically indicated per-oral endoscopic myotomy (POEM) using the Speedboat UltraSlim™ device * Able and willing to provide informed consent Exclusion Criteria: * Patients under 18 years of age * Patients not considered appropriate candidates for POEM by the principal investigator or treating physician
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Achalasia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Baylor College of Medicine
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Through-the-Mouth surgery vs keyhole surgery: which works better for a rare swallowing disorder?
- Could lying flat vs. on your side change esophageal test results?
- Nerve system glitches may worsen blood pressure swings during achalasia surgery — a study investigates
- New registry tracks POEM procedure for swallowing disorder
- Can fixing reflux fix your esophagus? new study investigates
- New study investigates why some patients get worse reflux after esophagus surgery